期刊文献+

A pharmacodynamic model of portal hypertension in isolated perfused rat liver 被引量:2

A pharmacodynamic model of portal hypertension in isolated perfused rat liver
下载PDF
导出
摘要 AIM: To develop a pharmacodynamic model of porta hypertension from chronic hepatitis. METHODS: Pathological changes and collagen depositions were analyzed using morphometry to confirm CCI4-induced chronic hepatitis. At do, d28, ds6 and d84 of the process, the portal perfused velocities (μL/min) in isolated rat livers were exactly controlled with a quanti-fied pump. The pressure (mmHg) was monitored with a Physiological System. The geometric concentrations of phenylephrine or acetylcholine were added to a fixed volume (300 mL) of the circulating perfusate. The equation, the median effective concentration and its 95% confidence intervals of phenylephrine or acetyl- choline were regressed with Prism-4 software in non-linear fit and various slopes. In the isolated perfused rat livers with chronic hepatitis, both median effective concentrations were defined as the pharmacodynamic model of portal hypertension.CONCLUSION: A pharmacodynamic model of portal hypertension in isolated perfused rat livers with chronic hepatitis was defined as the median effective concen- trations of phenylephrine and acetylcholine. AIM:To develop a pharmacodynamic model of portal hypertension from chronic hepatitis.METHODS:Pathological changes and collagen depositions were analyzed using morphometry to confirm CCl 4-induced chronic hepatitis.At d 0,d 28,d 56 and d 84 of the process,the portal perfused velocities (μL/min) in isolated rat livers were exactly controlled with a quantified pump.The pressure (mmHg) was monitored with a Physiological System.The geometric concentrations of phenylephrine or acetylcholine were added to a fixed volume (300 mL) of the circulating perfusate.The equation,the median effective concentration and its 95% confidence intervals of phenylephrine or acetylcholine were regressed with Prism-4 software in nonlinear fit and various slopes.In the isolated perfused rat livers with chronic hepatitis,both median effective concentrations were defined as the pharmacodynamic model of portal hypertension.RESULTS:At d 0,d 28,d 56 and d 84,the equations of portal pressure potency from the concentrations of phenylephrine used to constrict the portal vein in isolated perfused rat livers were Y=0.1732 + 0.3970/[1 + 10 (-4.3061-0.4407 X) ],Y=-0.004934 + 0.12113/[1 + 10 (-3.1247-0.3262 X) ],Y=0.0104 + 0.2643/[1 + 10 (-8.8462-0.9579 X) ],and Y=0.01603 + 0.12107/[1 + 10 (-5.1134-0.563 X) ];the median effective concentrations were 1.69 × 10-10 mol/L,2.64 × 10-10 mol/L,5.82 × 10-10 mol/L,and 8.24 × 10-10 mol/L,respectively.The equations from the concentrations of acetylcholine used to relax the portal vein were Y =-0.4548 + 0.3274/[1 + 10 (6.1538 + 0.5554 X) ],Y=-0.05391 + 0.06424/[1 + 10 (3.8541 + 0.3469 X) ],Y=-0.2733 + 0.22978/[1 + 10 (3.0472 + 0.3008 X) ],and Y=-0.0559 + 0.053178/[1 + 10 (5.6336 + 0.5883 X) ];the median effective concentrations were 8.40 × 10-10 mol/L,7.73 × 10-12 mol/L,5.98 × 10-11 mol/L,and 2.66 × 10-10 mol/L,respectively.CONCLUSION:A pharmacodynamic model of portal hypertension in isolated perfused rat livers with chronic hepatitis was defined as the median effective concentrations of phenylephrine and acetylcholine.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第5期472-478,共7页 世界胃肠病学杂志(英文版)
基金 Supported by The Major State Creative New Drug Project,No.2009ZX09502-017 Education Ministry Science Foundation ofChina,No. 108019
关键词 Chronic hepatitis Isolated portal perfusedrat liver Pharmacodynamic model Portal hypertension 大鼠肝脏 药效学 模型 高压 离体 慢性肝炎 乙酰胆碱 有效浓度
  • 相关文献

参考文献4

二级参考文献109

  • 1林述龙,陈兆东,林晓春,陈硕.甘利欣注射液治疗慢性乙型肝炎64例[J].中西医结合肝病杂志,2001,11(S1). 被引量:2
  • 2甄茂川,翁山耕,林永堃.ET-1在肝纤维化和门静脉高压中的作用[J].福建医药杂志,2004,26(3):169-171. 被引量:1
  • 3病毒性肝炎防治方案(试行)[J].中华传染病杂志,1995,13(4):241-247. 被引量:1767
  • 4陈厚皎 黄浩新.甘利欣对病毒性肝炎的疗效观察[J].广东医学,1999,20(7):560-560.
  • 5Roberts SE, Goldacre M J, Yeates D. Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999 [J]. Gut,2005, 54( 11 ) : 1615-1621.
  • 6Herath CB, Lubel JS, Jia Z, et al. Portal pressure responses and angiotensin peptide production in rat hver are determined by relative activity of angiotensin convetting enzyme ( ACE ) and ACE2 [ J ]. Am J Physiol Gastrointest Liver Physiol, 2009,297 ( 7 ) : G98 -G106.
  • 7Kerdok AE,Ottensmeyer MP,Howe RD. Effects of perfusion on the viscoelastic characteristics of liver[ J]. J Biomech ,2006,39(12) :2221-2231.
  • 8Xu CL, Cai DY, Tang CS. Pathogenesis of portal hypertension in liver cirrhosis rats dealt with CCl4[J]. World Chin J Digestol,2005,13(2) :235-238.
  • 9Chalhoub E, Hanson RW, Belovich JM. A computer model of gluconeogenesis and lipid metabolism in the perfused liver[ J]. Am J Physiol Endocrinol Metab, 2007,293 (6) : E1676 - E1686.
  • 10Brouwer I, Ustin J, Bentley L,et al. Measuring in vivo animal soft tissue properties for haptic modeling in surgical simulation [ J ]. Stud Health Technol Inform, 2001,81:69-74.

共引文献60

同被引文献26

  • 1郑家茂,熊宏齐.围绕研究型大学人才培养,建设开放创新的实践教学体系[J].高等工程教育研究,2008,56(3):94-97. 被引量:80
  • 2Mary A. Robinson,James E. Baumgardner,Cynthia M. Otto.Oxygen-dependent regulation of nitric oxide production by inducible nitric oxide synthase[J].Free Radical Biology and Medicine.2011(11)
  • 3Diana L. Diesen,Paul C. Kuo.Nitric Oxide and Redox Regulation in the Liver: Part I. General Considerations and Redox Biology in Hepatitis[J].Journal of Surgical Research.2010(1)
  • 4Jiang Junjie,Du Qinghong,Han Lin,Arezou Mashoufi,Li Pengtao.Effect of Glytan on the Expression of the Nicotinic Acetylcholine Receptor a7 in Portal Hypertensive Rats[J].World Science and Technology.2010(3)
  • 5Jaime Bosch,Annalisa Berzigotti,Juan Carlos Garcia-Pagan,Juan G. Abraldes.The management of portal hypertension: Rational basis, available treatments and future options[J].Journal of Hepatology.2008
  • 6Massimo Pinzani,Francesco Vizzutti.Fibrosis and Cirrhosis Reversibility: Clinical Features and Implications[J].Clinics in Liver Disease.2008(4)
  • 7Marjan NassiriAsl,HosseinHosseinzadeh.Review of Pharmacological Effects of Glycyrrhiza sp. and its Bioactive Compounds[J].Phytother Res.2008(6)
  • 8Fugen Aktan.iNOS-mediated nitric oxide production and its regulation[J].Life Sciences.2004(6)
  • 9Lutz W. D. Weber,Meinrad Boll,Andreas Stampfl.Hepatotoxicity and Mechanism of Action of Haloalkanes: Carbon Tetrachloride as a Toxicological Model[J].CRC Critical Reviews in Toxicology.2003(2)
  • 10Gomez-Sanchez EP,Gomez-Sanchez CE.Central hypertensinogenic effects of glycyrrhizic acid and carbenoxolone[].American Journal of Physiology.1992

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部